Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

APRI $1.85 0.1700 +10.12%
BPTH $1.20 0.0900 +8.11%
ONCY $0.54 0.0399 +7.98%
PVCT $0.56 0.0300 +5.66%
MEIP $1.77 0.0700 +4.12%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

LOXO $17.12 -1.0400 -5.73%
GERN $4.15 -0.2500 -5.68%
BLRX $2.50 -0.1500 -5.66%
MNTA $21.27 -1.1600 -5.17%
ENZN $1.21 -0.0600 -4.72%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Dr. Charles Littlejohn, Stamford, CT, Elected ASCRS President; Dr. Patricia Roberts, Burlington, MA, Chosen President-Elect

(Yahoo! Finance) June 30, 2015 - Dr. Charles E. Littlejohn, Stamford, CT, was elected President of the American Society of Colon and Rectal Surgeons (ASCRS) at the Society’s Annual Meeting in Boston, MA, succeeding Dr. Terry C. Hicks, New Orleans, LA.
read article 

New Medical Oncologist Joins The Hope Center for Cancer Care to Meet Growing Demand for Advanced Cancer Care Services

(The US Oncology Network) June 30, 2015 - The Hope Center for Cancer Care, a practice in The US Oncology Network providing comprehensive advanced cancer services, has added another medical oncologist to its staff. Sanaullah Khalid, M.D., will join the practice effective July 6, enhancing timely access to quality care for patients in the greater Warren-Youngstown metropolitan area.
read corporate press release 

Gregory Sutton Joins Tennessee Oncology

(The Chattanoogan) July 1, 2015 - Tennessee Oncology announced the arrival of Dr. Gregory Sutton, a medical oncologist who cares for patients at Tennessee Oncology Chattanooga’s Medical Park II location at 2200 East Third St. in Suite 100.
read article 

Transgenomic Launches Ultra-High Sensitive ICEme™ Mutation Enrichment Kits Enabling Turbocharged Cancer Research on Existing Platforms

(Transgenomic) July 1, 2015 - Transgenomic, Inc., a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that its ICEme™ Mutation Enrichment Kits for cancer research are now commercially available to researchers worldwide.
read corporate press release 

Kite Pharma and The Leukemia & Lymphoma Society(R) Enter Into Collaboration to Enhance the Development of KTE-C19 in Refractory Aggressive Non-Hodgkin Lymphoma and Launch CAR T-Cell Therapy Educational Programs

(Yahoo! Finance) July 1, 2015 - Kite Pharma, Inc., and The Leukemia & Lymphoma Society (LLS) announced today that they have entered into a partnership to enhance the development of Kite's lead product candidate, KTE-C19, for the treatment of patients with refractory aggressive non-Hodgkin lymphoma (NHL).
read article 

Baxalta Launches as a Global Biopharmaceutical Leader Dedicated to Patients with Orphan Diseases and Underserved Conditions

(The Street) July 1, 2015 - Baxalta to focus innovation on targeted therapies to advance leadership in hematology and immunology and to expand oncology business.
read article 

10 Years to Cancer Cures 'Actually Plausible,' Fred Hutch President Says

(Fred Hutch) June 30, 2015 - The future of cancer therapy looks “incredibly promising,” Dr. D. Gary Gilliland, president and director of Fred Hutchinson Cancer Research Center, said Tuesday.
read article 

Highmark, AHN Announce New Approach to Cancer Care

(Pittsburgh Business Times) June 30, 2015 - Health insurer Highmark Inc. and Allegheny Health Network are taking aim at the high cost of cancer care by tweaking treatment guidelines used by doctors while introducing new ways of paying for care.
read article 

Patients' Advocates Oppose Oncologists' 'Framework' For Care

(Consumer Affairs) July 1, 2015 - As health care costs rise and demand for services increases, we may see growing conflict between physicians who are trying to manage scarce and costly resources and groups advocating for the rights of patients.
read article 

Biocept Expands Blood-Based Test Menu to Identify Key Biomarker for Breast Cancer and Non-Small Cell and Small Cell Lung Cancers

(Yahoo! Finance) July 1, 2015 - Biocept, Inc., a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, today announced the launch of its FGFR1 amplification testing utilizing a patient's blood sample.
read article 

XBiotech Conducts Investigators Meeting to Update the Status of Its Phase III Registration Study Underway in Europe

(CNN Money) July 1, 2015 - XBiotech, the developer of True Human™ therapeutic antibodies, announced today that it held an investigators meeting to update clinicians and support staff on the overall status of the Company's Phase III study in colorectal cancer.
read article 

Dietary Supplements During Cancer Treatment: Yes or No?

(U.S. News & World Report) July 1, 2015 - Is it a good idea to take dietary supplements while going through active cancer treatment? It's a gray area.
read article 

Direct Link Between Wound Healing, Skin Cancer Seen by Researchers

(UPI) July 1, 2015 - Researchers have found that inflammatory cells sent by the immune system to the site of a wound for healing are redirected to pre-cancerous cells they help grow.
read article 

Protein’s Impact on Colorectal Cancer Is Dappled

(UC San Diego Health) June 30, 2015 - Researchers at University of California, San Diego School of Medicine have discovered a cell signaling pathway that appears to exert some control over initiation and progression of colorectal cancer, the third leading cause of cancer-related death in the United States.
read article 

Salmonella Bacterium Could Prove Potent Foe to Aggressive Form of Pancreatic Cancer

(Benzinga) July 1, 2015 - Patients with an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma currently have few good therapeutic options, with most medications able to increase survival by only a few months while exacting a high physical toll.
read article 

New Technology May Better Distinguish Brain Tumors From Healthy Tissue

(Medscape Medical News) June 30, 2015 - The use of new optical coherence tomography (OCT) technology may more accurately distinguish between brain tumor cells and healthy brain tissue, enabling more thorough removal of brain tumors without damaging normal brain cells, a new study suggests.
read article (free registration required) 

Implantable Devices at Risk During Cancer Radiotherapy

(MedPage Today) June 30, 2015 - Cancer patients with cardiovascular implantable electronic devices (CIEDs) who require radiotherapy may be at increased risk of a single-event upset malfunction when higher energy neutron-producing radiotherapy is used, a study now shows.
read article (free registration required) 

Managing Metastatic Colorectal CA: We Can Do Better

(MedPage Today/The Gupta Guide) June 30, 2015 - Despite modest, steady improvement over the past 20 years in managing metastatic colorectal cancer (mCRC), more experimental trials are needed to develop novel first-line therapies and better second-line treatments.
read article (free registration required) 

World GI 2015 Press Release: SENRI Trial Opens Window to Evaluate NK1 Antagonists for Emesis Prevention in Oxaliplatin Chemotherapy

(ESMO) July 1, 2015 - The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin chemotherapy, antiemetics expert and ESMO spokesperson Fausto Roila said, putting into perspective the results of a Japanese study presented today (1 July 2015) at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
read press release 

World GI 2015 Press Release: Patients with Lowest BMI Have Shortest Survival in Pooled Analysis of Bevacizumab in Metastatic Colorectal Cancer

(ESMO) July 1, 2015 - Patients with the lowest body mass index (BMI) had the shortest overall survival in an analysis of bevacizumab studies in metastatic colorectal cancer (mCRC) presented for the first time today (1 July 2015) at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
read press release 

Exelixis Provides Update on Genentech’s Pending New Drug Application for Cobimetinib, an Exelixis-Discovered Compound

(MarketWatch) July 1, 2015 - Yesterday, Exelixis’ partner Genentech, a member of the Roche Group, informed Exelixis that, in order to accommodate its review of a supplemental data submission, the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for its review of Genentech’s New Drug Application (NDA) for cobimetinib by the standard extension period of three months, from August 11, 2015 to November 11, 2015.
read article 

Which Companies Disclosed the Most to Open Payments

(Modern Healthcare) June 30, 2015 - Genentech, the maker of Avastin and other expensive cancer drugs, paid physicians and teaching hospitals more than any other drug or device company in 2014, according to a new round of data published Tuesday on the CMS' Open Payments website.
read article 

Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers

(Xconomy) June 30, 2015 - Exact Sciences’ ambitious plan to commercialize molecular diagnostic tests for several of the deadliest cancers is starting to come into focus.
read article 

Vertex Profits Hinge on FDA Approving New Cystic Fibrosis Drug This Week

(TheStreet) June 29, 2015 - Vertex Pharmaceuticals is widely expected to win U.S. approval later this week for a new drug which could one day treat almost half of cystic fibrosis patients.
read article 

Novartis to Test New Pricing Model With Heart Failure Drug

(Reuters) June 30, 2015 - Novartis plans to test a novel pricing model with some customers when it launches its keenly awaited new heart failure drug Entresto, the Swiss company's head of pharmaceuticals said on Tuesday.
read article